Adult Immunization Schedule, 2022

Recommendations for Ages 19 Years or Older, United States, 2022

¶ = Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of past infection
§ = Recommended vaccination for adults with an additional risk factor or another indication
± = Recommended vaccination based on shared clinical decision-making
⇒ = No recommendation/Not applicable

adult vaccine schedule
Vaccine	19-26 years		27-49 years				50-64 years				≥65 years
Influenza inactivated (IIV4) or Influenza recombinant (RIV4)	¶		1 dose annually¶				¶				¶
Influenza live attenuated (LAIV4)	¶		1 dose annually¶				⇒				⇒
Tetanus, diphtheria, pertussis (Tdap or Td)	1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (see notes)§
Tetanus, diphtheria, pertussis (Tdap or Td)	1 dose Tdap, then Td or Tdap booster every 10 years¶
Measles, mumps, rubella (MMR)	1 or 2 doses depending on indication (if born in 1957 or later)¶										⇒
Varicella (VAR)	2 doses (if born in 1980 or later)¶			¶	§	2 doses§
Zoster recombinant (RZV)	2 doses for immunocompromising conditions (see notes)§						2 doses¶
Human papillomavirus (HPV)	2 or 3 doses depending on age at initial vaccination or condition¶		27 through 45 years±		±	⇒	⇒				⇒
Pneumococcal (PCV15, PCV20, PPSV23)	1 dose PCV15 followed by PPSV23 OR 1 dose PCV20 (see notes)§										1 dose PCV15 followed by PPSV23 OR 1 dose PCV20¶
Hepatitis A (HepA)	2 or 3 doses depending on vaccine§
Hepatitis B (HepB)	2, 3, or 4 doses depending on vaccine or condition¶							¶	¶	§	§
Meningococcal A, C, W, Y (MenACWY)	1 or 2 doses depending on indication, see notes for booster recommendations§
Meningococcal B (MenB)	§	2 or 3 doses depending on vaccine and indication, see notes for booster recommendations§
Meningococcal B (MenB)	19 through 23 years±	§	§
Haemophilus influenzae type b (Hib)	1 or 3 doses depending on indication§

Top of Page